Trial Profile
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Total Hip Arthroplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2019
Price :
$35
*
At a glance
- Drugs Opiranserin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Vivozon
- 11 Mar 2019 Status changed from recruiting to completed.
- 22 Nov 2017 New trial record